Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Fallers
Why Advance NanoTek, Incitec Pivot, Starpharma, & Zoono are tumbling lower
Share Gainers
Why Novonix, Recce, Singular Health, & Starpharma shares are storming higher
Share Gainers
Here's why the Starpharma (ASX:SPL) share price just stormed to a record high
Share Gainers
Why Douugh, Macquarie, Starpharma, & Suncorp shares are storming higher
Share Gainers
Why the Starpharma (ASX:SPL) share price hit a record high today
Share Market News
Starpharma (ASX:SPL) share price dips on quarterly update
Share Market News
Leading broker names the ASX healthcare shares to buy in 2021
Healthcare Shares
Are these 4 ASX medical shares set for a healthy 2021?
Share Gainers
Why Asaleo Care, Fortescue, Perpetual, & Starpharma shares are storming higher
Share Gainers
Starpharma (ASX:SPL) share price jumps 15% after COVID-19 nasal spray update
Share Gainers
Why the Starpharma (ASX:SPL) share price is racing higher today
Share Fallers
Why BHP, Estia Health, Newcrest, & Starpharma shares are dropping lower
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
